Myriad Genetics, Inc.
News
Heinrich Dreismann Sells 10,000 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN) Stock
Ticker Report Myriad Genetics, Inc. (NASDAQ:MYGN - Get Free Report) Director Heinrich Dreismann sold 10,000 shares of the stock in a transaction dated Monday, September 9th. The stock was sold at an average price...\n more…
Myriad (MYGN) Down 4.8% Since Last Earnings Report: Can It Rebound?
Zacks Investment Research A month has gone by since the last earnings report for Myriad Genetics (MYGN). Shares have lost about 4.8% in that time frame, underperforming the S&P 500.Will the recent negative trend continue...\n more…
Myriad Genetics to Host Investor Event on October 9, 2024
Globe Newswire SALT LAKE CITY, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, will host an Investor Event at the Westin Grand Central...\n more…
Myriad Genetics, Inc. (NASDAQ:MYGN) Director Colleen F. Reitan Sells 46,012 Shares
Ticker Report Myriad Genetics, Inc. (NASDAQ:MYGN - Get Free Report) Director Colleen F. Reitan sold 46,012 shares of the company's stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold...\n more…
Why Myriad Genetics (MYGN) is a Top Momentum Stock for the Long-Term
Zacks Investment Research It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different...\n more…
Myriad Genetics, Inc.'s (NASDAQ:MYGN) Price Is Right But Growth Is Lacking
Simply Wall St You may think that with a price-to-sales (or "P/S") ratio of 3.2x Myriad Genetics, Inc. ( NASDAQ:MYGN ) is definitely a...\n more…